In Patients with Resectable Oral Squamous Cell Carcinoma of the Tongue, Prognostic Factors, Failure Patterns, and Survival Analysis Were Examined
Authors/Creators
- 1. Senior Resident, Patna Medical College Hospital, Patna, Bihar, India
- 2. Senior Resident, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India
Description
Purpose: Resectable oral tongue squamous cell carcinoma has little evidence on treatment results (OTSCC). In this investigation, treatment outcomes for resectable OTSCC were evaluated, failure patterns were investigated, and potential clinicopathological prognostic variables influencing treatment outcomes were identified. Materials and Methods: It is a retrospective review of 202 patients with resectable OTSCC who underwent main upfront surgery, adjuvant radiation, and concomitant chemotherapy as needed. Results: The average follow-up period was 35.2 months (range, 1.2 to 99.9 months). Locoregional control (LRC) lasted an average of 84.9 months (95% confidence interval: 67.3-102.4). The LRC rate across three and five years was 68.5% and 58.3%, respectively. Increased pT stage, increased pN stage, and the presence of extracapsular extension (ECE) were substantially linked with worse LRC, according to multivariate analysis. At the time of study, the median overall survival time (OS) had not been attained. The 3- and 5-year OS rates were, respectively, 70.5% and 66.6%. Increasing pT stage and the presence of ECE were strongly related with a worse OS, according to multivariate analyses. Conclusion: In resectable OTSCC, locoregional failure continues to be the primary factor in treatment failure. Given the low LRC and OS, there is potential to significantly improve the prognosis. Strong prognostic variables include the pathological T-stage, N-stage, and ECE. To confirm whether adjuvant therapy improves treatment outcomes in instances with lymphovascular invasion, depth of invasion and perineural invasion and to assist doctors in customising adjuvant therapy, more study is needed.
Abstract (English)
Purpose: Resectable oral tongue squamous cell carcinoma has little evidence on treatment results (OTSCC). In this investigation, treatment outcomes for resectable OTSCC were evaluated, failure patterns were investigated, and potential clinicopathological prognostic variables influencing treatment outcomes were identified. Materials and Methods: It is a retrospective review of 202 patients with resectable OTSCC who underwent main upfront surgery, adjuvant radiation, and concomitant chemotherapy as needed. Results: The average follow-up period was 35.2 months (range, 1.2 to 99.9 months). Locoregional control (LRC) lasted an average of 84.9 months (95% confidence interval: 67.3-102.4). The LRC rate across three and five years was 68.5% and 58.3%, respectively. Increased pT stage, increased pN stage, and the presence of extracapsular extension (ECE) were substantially linked with worse LRC, according to multivariate analysis. At the time of study, the median overall survival time (OS) had not been attained. The 3- and 5-year OS rates were, respectively, 70.5% and 66.6%. Increasing pT stage and the presence of ECE were strongly related with a worse OS, according to multivariate analyses. Conclusion: In resectable OTSCC, locoregional failure continues to be the primary factor in treatment failure. Given the low LRC and OS, there is potential to significantly improve the prognosis. Strong prognostic variables include the pathological T-stage, N-stage, and ECE. To confirm whether adjuvant therapy improves treatment outcomes in instances with lymphovascular invasion, depth of invasion and perineural invasion and to assist doctors in customising adjuvant therapy, more study is needed.
Files
IJPCR,Vol15,Issue2,Article122.pdf
Files
(283.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:65ba699fbe47d3a698d0aec279249ea4
|
283.6 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-02-28
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue2,Article122.pdf
- Development Status
- Active
References
- 1. Myers JN, Elkins T, Roberts D, Byers RM. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 2000; 122:44-51. 2. Annertz K, Anderson H, Biorklund A, et al. Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer 2002; 101:95-9. 3. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20- 44 years. Cancer 2005; 103:1843-9. 4. Fein DA, Mendenhall WM, Parsons JT, et al. Carcinoma of the oral tongue: a comparison of results and complications of treatment with radiotherapy and/or surgery. Head Neck 1994; 16:358-65.5. Lefebvre JL, Coche-Dequeant B, Buisset E, Mirabel X, Van JT, Prevost B. Management of early oral cavity cancer: experience of Centre Oscar Lambret. Eur J Cancer B Oral Oncol 1994;30B:216-20. 6. Lapeyre M, Bollet MA, Racadot S, et al. Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins. Head Neck 2004; 26:216-23. 7. Rusthoven K, Ballonoff A, Raben D, Chen C. Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer 20 08; 112:345-51. 8. Cheng YJ, Tsai MH, Chiang CJ, et al. Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome-A Taiwan Cancer Registry national database analysis. Cancer Med 2018 Jun 14 [Epub]. 9. Micheli A, Mariotto A, Giorgi Rossi A, Gatta G, Muti P. The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group. Eur J Cancer 1998;34(14 Spec No):2271-8. 10. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 2002; 24:165-80. 11. Franco EL, Dib LL, Pinto DS, Lombardo V, Contesini H. Race and gender influences on the survival of patients with mouth cancer. J Clin Epidemiol 1993; 46:37-46. 12. Listl S, Jansen L, Stenzinger A, et al. Survival of patients with oral cavity cancer in Germany. PLoS One 2013;8: e53415. 13. Garavello W, Spreafico R, Somigliana E, Gaini L, Pignataro L, Gaini RM. Prognostic influence of gender in patients with oral tongue cancer. Otolaryngol Head Neck Surg 2008; 138:768-71. 14. Bhattacharyya N. A matched survival analysis for squamous cell carcinoma of the head and neck in the elderly. Laryngoscope 2003; 113:368-72. 15. Leoncini E, Vukovic V, Cadoni G, et al. Clinical features and prognostic factors in patients with head and neck cancer: results from a multicentric study. Cancer Epidemiol 2015; 39:367- 74. 16. Li Y, Mao Y, Zhang Y, et al. Alcohol drinking and upper aerodigestive tract cancer mortality: a systematic review and meta-analysis. Oral Oncol 2014; 50:269-75. 17. Inoue M, Nagata C, Tsuji I, et al. Impact of alcohol intake on total mortality and mortality from major causes in Japan: a pooled analysis of six large-scale cohort studies. J Epidemiol Community Health 2012; 66:448-56. 18. Kim MK, Ko MJ, Han JT. Alcohol consumption and mortality from allcause and cancers among 1.34 million Koreans: the results from the Korea national health insurance corporation's health examinee cohort in 2000. Cancer Causes Control 2010; 21:2295- 302. 19. Sawabe M, Ito H, Oze I, et al. Heterogeneous impact of alcohol consumption according to treatment method on survival in head and neck cancer: a prospective study. Cancer Sci 2017; 108:91-100. 20. Thiagarajan S, Nair S, Nair D, et al. Predictors of prognosis for squamous cell carcinoma of oral tongue. J Surg Oncol 2014; 109:639-44. 21. Kirita T, Ohgi K, Shimooka H, et al. Preoperative concurrent chemoradiot herapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of longterm results. Oral Oncol 1999; 35:597- 606.22. Jones HB, Sykes A, Bayman N, et al. The impact of lymphovascular invasion on survival in oral carcinoma. Oral Oncol 2009; 45:10-5. 23. Yanamoto S, Yamada S, Takahashi H, et al. Clinicopathological risk factors for local recurrence in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2012; 41:1195-200. 24. Lin CY, Wang HM, Kang CJ, et al. Primary tumor site as a predictor of treatment outcome for definitive radiotherapy of advanced-stage oral cavity cancers. Int J Radiat Oncol Biol Phys 2010; 78:1011-9. 25. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005; 27:843-50. 26. Myers JN, Greenberg JS, Mo V, Roberts D. Extracapsular spread: a significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 2001; 92:3030-6. 27. Metcalfe E, Aspin L, Speight R, et al. Postoperative (chemo) radiotherapy for oral cavity squamous cell carcinomas: outcomes and patterns of failure. Clin Oncol (R Coll Radiol) 2017; 29:51-9. 28. Abdulabbas H. S., Abed S. Y., Mahdi Z. A. A., Al-Hindy H. A. A. M., Akram M., Laila U., Zainab R., AlKhafaji N. S., Al-Dahmoshi H. O., & Chabuck Z. A. G. Antiviral effects of medicinal plants: Minireview. Journal of Medical Research and Health Sciences. 2023; 6(2): 2424–2429.